{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:42Z","timestamp":1753890582974,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front.Allergy"],"DOI":"10.3389\/falgy.2021.660447","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:14:52Z","timestamp":1614917692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Contemporary Grand Challenges and Opportunities in Skin Allergies"],"prefix":"10.3389","volume":"2","author":[{"given":"Bettina","family":"Wedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000507218","article-title":"Urticaria: collegium internationale allergologicum (CIA) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1900408","article-title":"Ligelizumab for chronic spontaneous urticaria","volume":"381","author":"Maurer","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/ITT.S261416","article-title":"Anti-IgE for the treatment of chronic urticaria","volume":"10","author":"Wedi","year":"2021","journal-title":"ImmunoTargets Therapy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coi.2018.05.015","article-title":"Targeting IgE in allergic disease","volume":"54","author":"Gasser","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"K\u00fchn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/cea.13558","article-title":"Evidence for bradykinin release in chronic spontaneous urticaria","volume":"50","author":"Hofman","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/14728222.2019.1608949","article-title":"Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets","volume":"23","author":"Farkas","year":"2019","journal-title":"Exp Opin Ther Targ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/all.14631","article-title":"The European academy of allergy, clinical immunology atopic dermatitis guideline group. systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis","author":"Siegels","year":"2020","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaci.2020.04.062","article-title":"Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers","volume":"147","author":"Bakker","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/modpathol.2013.117","article-title":"Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis","volume":"27","author":"Berezowska","year":"2014","journal-title":"Mod Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/all.14069","article-title":"Network for Online Registration of Anaphylaxis (NORA). Secondary prevention measures in anaphylaxis patients: data from the anaphylaxis registry","volume":"75","author":"Kraft","year":"2020","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: from mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/14656566.2020.1775815","article-title":"Current and emerging systemic treatments targeting the neural system for chronic pruritus","volume":"21","author":"Golpanian","year":"2020","journal-title":"Exp Opin Pharmacother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.anai.2020.10.003","article-title":"A review of contact dermatitis","volume":"126","author":"Brar","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cod.13584","article-title":"Review of biologics in allergic contact dermatitis","volume":"83","author":"Bhatia","year":"2020","journal-title":"Contact Dermatitis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1038\/d41586-020-03524-6","article-title":"The skin microbiome and its relationship with the human body explained","volume":"588","author":"Eisenstein","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2021.1874353","article-title":"The clinical implications of the microbiome in the development of allergy diseases","volume":"19","author":"Koidl","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40629-020-00126-6","article-title":"Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events","volume":"12","author":"G\u00fclsen","year":"2020","journal-title":"Allergo J Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"547654","DOI":"10.3389\/falgy.2020.547654","article-title":"Current grand challenges in allergy","volume":"1","author":"Papadopoulos","year":"2020","journal-title":"Front. Allergy"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.660447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:14:54Z","timestamp":1614917694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.660447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":24,"alternative-id":["10.3389\/falgy.2021.660447"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2021.660447","relation":{},"ISSN":["2673-6101"],"issn-type":[{"type":"electronic","value":"2673-6101"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"article-number":"660447"}}